Orbimed Capital Llc (CIK 0001157524)

Latest company ownership

Shares held
6,589,330
Last filed at
Mar 31, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
526,300
Last filed at
May 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
415,142
Last filed at
Jun 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
96,190
Last filed at
Sep 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ALEC - Alector, Inc.
Role: 10% Owner
Shares held
0
Last filed at
Mar 4, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 26, 2024 Aug 28, 2024 ARS Pharmaceuticals, Inc. Director Sell 17.5 -83,695 -100.00% ✗ $1.1M
Aug 21, 2024 Aug 23, 2024 ARS Pharmaceuticals, Inc. Director Sell 15.0 -868,682 -91.21% ✗ $11.5M
Aug 29, 2023 Aug 31, 2023 ARS Pharmaceuticals, Inc. Director Buy 95.0 +500,000 6.65% ✗ $3.1M
May 22, 2023 May 24, 2023 Prelude Therapeutics Inc Director Buy 95.0 +869,565 9.40% ✗ $5M
Jun 24, 2022 Jun 28, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 16.3 -341,971 -7.97% ✗ $7.3M
Apr 6, 2022 Apr 8, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 15.0 -878,200 -6.06% ✗ $18.2M
Mar 29, 2022 Mar 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 15.0 -474,500 -100.00% ✗ $10.3M
Sep 3, 2021 Sep 8, 2021 Repare Therapeutics Inc. Director Sell 47.5 -8,084 -0.12% ✓ $274.8K
Aug 31, 2021 Sep 2, 2021 Repare Therapeutics Inc. Director Sell 43.8 -37,864 -0.38% ✓ $1.3M
Aug 26, 2021 Aug 30, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,073 -0.18% ✓ $615.7K
Aug 23, 2021 Aug 25, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,215 -0.18% ✓ $622.4K
Aug 17, 2021 Aug 19, 2021 Repare Therapeutics Inc. Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Jul 16, 2021 Jul 16, 2021 Enliven Therapeutics, Inc. Director Buy 100.0 +1,666,666 100.00% ✗ $10M
Dec 8, 2020 Dec 8, 2020 ARS Pharmaceuticals, Inc. Director Buy 100.0 +1,190,477 221.01% ✗ $25M
Oct 2, 2020 Oct 6, 2020 Arcutis Biotherapeutics, Inc. Director Buy 100.0 +496,000 10.61% ✗ $12.4M
Sep 25, 2020 Sep 29, 2020 Prelude Therapeutics Inc Director Buy 100.0 +1,236,800 597.74% ✗ $23.5M
Sep 25, 2020 Sep 29, 2020 PMV Pharmaceuticals, Inc. Director Buy 100.0 +950,000 100.00% ✗ $17.1M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. Director Buy 100.0 +774,200 29.76% ✗ $15.5M
Mar 2, 2020 Mar 4, 2020 Alector, Inc. 10% Owner Sell 15.0 -1,874,203 -17.70% ✗ $48.7M
Feb 3, 2020 Feb 4, 2020 Arcutis Biotherapeutics, Inc. Director Buy 100.0 +558,888 100.00% ✗ $9.5M
Jan 9, 2020 Jan 13, 2020 Alector, Inc. 10% Owner Sell 16.3 -379,997 -3.46% ✗ $7.4M
Dec 20, 2019 Dec 26, 2019 Alector, Inc. 10% Owner Sell 15.0 -519,385 -1.16% ✗ $10.2M
Dec 17, 2019 Dec 19, 2019 Alector, Inc. 10% Owner Sell 15.0 -954,100 -7.67% ✗ $17.7M
Aug 7, 2019 Aug 9, 2019 Alector, Inc. 10% Owner Sell 15.0 -650,000 -5.04% ✗ $11.6M
Feb 11, 2019 Feb 11, 2019 Alector, Inc. Director Buy 93.8 +411,700 3.25% ✗ $7.8M